Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 85 entries
View as:

Study of the Large Diameter GORE EXCLUDER® AAA Endoprosthesis in Abdominal Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT00615069 Org: User:
Start: 05/31/06 End: 06/30/14 Due: 06/30/15

GORE Glaucoma Drainage Implant Clinical Study Dominican Republic

Phase: N/A Priority: Normal
NCT ID: NCT05557058 Org: User:
Start: 09/14/22 End: 04/30/26 Due: 04/30/27

Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Phase: N/A Priority: Normal
NCT ID: NCT01711983 Org: User:
Start: 10/31/12 End: 11/26/18 Due: 11/26/19

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

Phase: N/A Priority: Normal
NCT ID: NCT06556654 Org: User:
Start: 04/09/25 End: 09/30/29 Due: 09/30/30

Evaluation of Anti-platelet Factor 4/Heparin Antibodies in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02165761 Org: User:
Start: 07/31/14 End: 01/20/17 Due: 01/20/18

GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft

Phase: N/A Priority: Normal
NCT ID: NCT00617279 Org: User:
Start: 12/31/07 End: 02/28/10 Due: 02/28/11

GORE Embolic Protection With Reverse Flow

Phase: N/A Priority: Normal
NCT ID: NCT00594100 Org: User:
Start: 07/31/06 End: 09/30/08 Due: 09/30/09

GORE EXCLUDER® Endoprosthesis - Low Permeability in Treatment of Abdominal Aortic Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT00593814 Org: User:
Start: 06/30/05 End: 02/28/09 Due: 02/28/10

The Gore SCAFFOLD Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT01901874 Org: User:
Start: 07/31/13 End: 09/30/20 Due: 09/30/21

Multi-center Study for Stent Graft System for Peripheral Artery

Phase: N/A Priority: Normal
NCT ID: NCT01575808 Org: User:
Start: 04/30/12 End: 02/28/19 Due: 02/28/20

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

Phase: N/A Priority: Normal
NCT ID: NCT06827990 Org: User:
Start: 09/01/25 End: 09/01/31 Due: 09/01/32

The GORE® VIAFORT Vascular Stent IVC Study

Phase: N/A Priority: Normal
NCT ID: NCT05409976 Org: User:
Start: 10/25/22 End: 05/31/30 Due: 05/31/31

Early Feasibility of the Branched TAG® Device in the Treatment of Aortic Arch Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT02264977 Org: User:
Start: 04/30/15 End: 03/31/22 Due: 03/31/23

GORE® CARDIOFORM Septal Occluder Migraine Clinical Study

Phase: N/A Priority: Normal
NCT ID: NCT04100135 Org: User:
Start: 02/05/21 End: 08/15/24 Due: 08/15/25

GORE® Septal Occluder European Union Clinical Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT01605851 Org: User:
Start: 05/31/12 End: 04/30/14 Due: 04/30/15

Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access

Phase: N/A Priority: Normal
NCT ID: NCT05124184 Org: User:
Start: 01/24/22 End: 07/22/24 Due: 07/22/25

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End Stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT04671771 Org: User:
Start: 12/03/20 End: 07/01/29 Due: 07/01/30

VIATORR Device Registry

Phase: N/A Priority: Normal
NCT ID: NCT05661331 Org: User:
Start: 02/21/23 End: 12/31/28 Due: 12/31/29

Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL

Phase: N/A Priority: Normal
NCT ID: NCT03286400 Org: User:
Start: 10/18/17 End: 10/09/19 Due: 10/09/20

Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement

Phase: N/A Priority: Normal
NCT ID: NCT01325792 Org: User:
Start: 02/28/11 End: 12/31/14 Due: 12/31/15

Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT03441971 Org: User:
Start: 06/07/18 End: 03/31/30 Due: 03/31/31

Evaluation of the GORE® C3 Delivery System Module

Phase: N/A Priority: Normal
NCT ID: NCT01398332 Org: User:
Start: 01/31/11 End: 07/31/24 Due: 07/31/25

Clinical Outcomes of the Gore Synthetic Cornea Device

Phase: N/A Priority: Normal
NCT ID: NCT06174376 Org: User:
Start: 08/19/24 End: 12/31/30 Due: 12/31/31

GORE Flow Reversal System and GORE Embolic Filter Extension Study

Phase: N/A Priority: Normal
NCT ID: NCT01343667 Org: User:
Start: 04/30/11 End: 01/31/14 Due: 01/31/15

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

Phase: N/A Priority: Normal
NCT ID: NCT02777593 Org: User:
Start: 09/06/16 End: 12/31/27 Due: 12/31/28